Shahinaz M Gadalla

No ORCID on file · 2 papers in corpus
observational 2019
Frontiers in neurology ·doi:10.3389/fneur.2019.01071

Introduction: Recent evidence demonstrates that women with myotonic dystrophy type 1 are at increased risk of reproductive organ tumors. However, studies of reproductive cancer risk factors in those patients are lacking. Methods: Using ques…

review 2018
Neurology. Clinical practice ·doi:10.1212/cpj.0000000000000531

PURPOSE OF REVIEW: Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects between 1 in 3,000 and 8,000 individuals globally. No evidence-based guideline exists to inform the care of these patients, and most do…